Balchem reports record Q3 2021 sales of $197.9M, net earnings $25.0M, EPS $0.77

BALCHEM CORP

2021-Q3 EPS reported $2.18 revenue$585,890,000

Net sales $197.9M, up 13% YoY; record sales in all three segments: Human Nutrition, Animal Nutrition, and Specialty Products.
GAAP EPS $0.77; adjusted EPS $0.92 vs $0.83 prior year; adjusted EBITDA $48.3M, up 9%.
Cash flow from operations $39.6M, free cash flow $31.1M, both up YoY.
Started new Metalosate production line in Marano, Italy to serve international customers.
Completed ERP consolidation to Microsoft Dynamics 365 on budget and on time.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.